参考文献/References:
[1] THOMAS R, Lee Y C. Causes and management of
common benign pleural effusions[J]. Thorac Surg Clin,
2013, 23(1):25-42, v-vi.
[2] STEAD WW, EICHENHOLZ A, STAUSS H K.
Operative and pathologic findings in twenty-four
patients with syndrome of idiopathic pleurisy with
effusion, presumably tuberculous[J]. Am Rev Tuberc,
1955, 71(4):473-502.
[3] 刘家云, 郝晓柯. 结核病实验室诊断方法新进展[J].
临床检验杂志, 2013, 31(2):115-117.
LIU Jiayun, HAO Xiaoke. New progress in laboratory
diagnosis of tuberculosis [J] Chinese. Journal of
Clinical Laboratory Science, 2013, 31 (2):115-117.
[4] 姜世闻. 《结核病分类》和《肺结核诊断》新标准
对结核病控制工作的影响[J]. 中国防痨杂志, 2018,
40(3):229-230.
JIANG Shiwen. The impact of new TB classification
and TB diagnosis standards on TB control [J]. Chinese
Journal of Antituberculosis, 2018, 40 (3): 229-230.
[5] World Health Organization. Automated real-time
nucleic acid amplification technology for rapid and
simultaneous detection of tuberculosis and rifampicin
resistance: Xpert MTB/RIF assay for the diagnosis
of pulmonary and ext·rapulmonary TB in adults and
children: policy update[M]. Geneva: WHO, 2014.
[6] LUSIBA J K, NAKIYINGI L, KIRENGA B J, et al.
Evaluation of cepheid’s Xpert MTB/Rif test on pleural
fluid in the diagnosis of pleural tuberculosis in a
high prevalence HIV/TB setting[J]. PLoS One, 2014,
9(7):e102702.
[7] RUFAI S B, SINGH A, KUMAR P, et al. Performance
of Xpert MTB/RIF assay in diagnosis of pleural
tuberculosis by use of pleural fluid samples[J]. J Clin
Microbiol, 2015, 53(11):3636-3638.
[8] PORCEL J M, PALMA R, VALDES L, et al.
Xpert(R) MTB/RIF in pleural fluid for the diagnosis
of tuberculosis[J]. Int J Tuberc Lung Dis, 2013,
17(9):1217-1219.
[9] SAEED M, AHMAD M, IRAM S, et al. GeneXpert
technology. A breakthrough for the diagnosis of
tuberculous pericarditis and pleuritis in less than 2
hours[J]. Saudi Medical Journal, 2017, 38(7):699-
705.
[10] VAN RIE A, MELLEt K, JOHN M A, et al. Falsepositive
rifampicin resistance on Xpert(R) MTB/RIF:
case report and clinical implications[J]. Int J Tuberc
Lung Dis, 2012, 16(2):206-208.
[11] FRIEDRICH S O, VON GROOTE-BIDLINGMAIER
F, DIACON A H. Xpert MTB/RIF assay for diagnosis
of pleural tuberculosis[J]. J Clin Microbiol, 2011,
49(12):4341-4342.
[12] ARDIZZONI E, FAJARDO E, SARANCHUK P, et al.
Implementing the Xpert? MTB/RIF diagnostic test for
tuberculosis and rifampicin resistance: outcomes and
lessons learned in 18 countries[J]. PLoS One, 2015,
10(12):e0144656.
[13] VADWAI V, BOEHME C, NABETA P, et al. Xpert MTB/
RIF: a new pillar in diagnosis of extrapulmonary
tuberculosis?[J]. J Clin Microbiol, 2011, 49(7):2540-
2545.
[14] DENKINGER C M, SCHUMACHER S G, BOEHME
C C, et al. Xpert MTB/RIF assay for the diagnosis
of extrapulmonary tuberculosis: a systematic
review and meta-analysis[J]. Eur Respir J, 2014,
44(2):435-446.
[15] DU Jinghui, HUANG Zikun, LUO Qing, et al. Rapid
diagnosis of pleural tuberculosis by Xpert MTB/
RIF assay using pleural biopsy and pleural fluid
specimens[J]. Journal of Research in Medical Sciences:
the Official Journal of Isfahan University of Medical
Sciences, 2015, 20(1):26-31.
[16] 涂盛锦, 黄汉平, 曹珊. 浓缩胸腔积液Gene Xpert
MTB/RIF 试验在结核性胸膜炎快速诊断中的应用价
值[J]. 临床内科杂志, 2019, 36(1):44-46.
TU Shengjin, HUANG Hanping, CAO Shan. Application
value of concentrated pleural effusion Gene Xpert
MTB/RIF test in rapid diagnosis of tuberculous pleurisy
[J]. Journal of Clinical Internal Medicine, 2019,
36(1):44-46.
[17] AREF H. Diagnostic utility of QuantiFERON-TB Gold
and Xpert MTB/RIF combined with adenosine deaminase
in tuberculous pleural effusion: a prospective
study[J]. Egyption Journal of Bronchology, 2017,
11(4):346-354.
[18] PANDEY P, PANT N D, RIJAl K R, et al. Diagnostic
accuracy of GeneXpert MTB/RIF assay in comparison
to conventional drug susceptibility testing method for
the diagnosis of multidrug-resistant tuberculosis[J].
PLoS One, 2017, 12(1):e0169798.
[19] HUANG Hai, ZHANG Yanlin, LI Sheng, et al.
Rifampicin resistance and multidrug-resistant
tuberculosis detection using Xpert MTB/RIF in Wuhan,
China: a retrospective study[J]. Microb Drug Resist,
2018, 24(5):675-679.
[20] OCHERETINA O, BYRT E, MABOU M M, et al.
False-positive rifampin resistant results with Xpert
MTB/RIF version 4 assay in clinical samples with a
low bacterial load[J]. Diagn Microbiol Infect Dis, 2016,
85(1):53-55.
[21] World Health Organization. Xpert MTB/RIF implementation
manual: technical and operational ‘how-to’;
practical considerations[M]. Geneva: World Health Organization,
2014.
[22] ABLANEDO-TERRAZAS Y, ALVARADO-DE LA BARRERA
C, HERNANDEZ-JUAN R, et al. Xpert MTB/
RIF for diagnosis of tuberculous cervical lymphadenitis
in HIV-infected patients[J]. Laryngoscope, 2014,
124(6):1382-1385.
[23] MARJANI M, YOUSEFZADEH A, BAGHAEI P, et al.
Impact of HIV infection on tuberculous pleural effusion[J].
International Journal of STD & AIDS, 2016, 27(5):363-
369.
[24] SINGH M, SETHI G R, MANTAN M, et al. Xpert(?)
MTB/RIF assay for the diagnosis of pulmonary tuberculosis
in children[J]. Int J Tuberc Lung Dis, 2016, 20(6):839-
843.
[25] STEINGART K R, SCHILLER I, Horne D J, et al.
Xpert(R) MTB/RIF assay for pulmonary tuberculosis
and rifampicin resistance in adults[J]. Cochrane
Database Syst Rev, 2014(1):CD009593.
[26] DETJEN A K, DINARDO AR, LEYDEN J, et al. Xpert
MTB/RIF assay for the diagnosis of pulmonary
tuberculosis in children: a systematic review
and meta-analysis[J]. Lancet Respir Med, 2015,
3(6):451-461.
[27] LACOURSE SM, PAVLINAC PB, Cranmer LM, et al.
Stool Xpert MTB/RIF and urine lipoarabinomannan
for the diagnosis of tuberculosis in hospitalized HIVinfected
children[J]. AIDS, 2018, 32(1):69-78.
[28] BATES M, O’GRADY J, MAEURER M, et al. Assessment
of the Xpert MTB/RIF assay for diagnosis of
tuberculosis with gastric lavage aspirates in children in
sub-Saharan Africa: a prospective descriptive study[J].
Lancet Infectious Diseases, 2013, 13(1):36-42.
[29] AL-ATEAH S M, AL-DOWAIDI M M, EL-KHIZZI N A.
Evaluation of direct detection of Mycobacterium tuberculosis
complex in respiratory and non-respiratory clinical
specimens using the Cepheid Gene Xpert(R) system[J].
Saudi Med J, 2012, 33(10):1100-1105.
[30] BISOGNIN F, LOMBARDI G, LOMBARDO D, et al.
Improvement of Mycobacterium tuberculosis detection
by Xpert MTB/RIF Ultra: A head-to-head comparison
on Xpert-negative samples[J]. PLoS One, 2018,
13(8):e0201934. .
[31] CHAKRAVORTY S, SIMMONS A M, ROWNEKI M, et al.
The new Xpert MTB/RIF Ultra: improving detection of
Mycobacterium tuberculosis and resistance to rifampin
in an assay suitable for point-of-care testing[J]. mBio,
2017, 8(4): e00812-17.
[32] BAHR N C, NUWAGIRA E, EVANS E E, et al. Diagnostic
accuracy of Xpert MTB/RIF Ultra for
tuberculous meningitis in HIV-infected adults: a
prospective cohort study[J]. Lancet Infect Dis,
2018, 18(1):68-75.
[33] NICOL M P, WORKMAN L, PRINS M, et al. Accuracy
of Xpert Mtb/Rif Ultra for the diagnosis of pulmonary
tuberculosis in children[J]. The Pediatric Infectious
Disease Journal, 2018, 37(10):e261-e263.
[34] SABI I, RACHOW A, MAPAMBA D, et al. Xpert
MTB/RIF Ultra assay for the diagnosis of pulmonary
TB in children: a multi-centre comparative accuracy
study[J]. The Journal of Infection, 2018, 77(4):321-
327.
[35] WU Xiaocui, TAN Guangkun, GAO Rongliang, et al.
Assessment of the Xpert MTB/RIF Ultra assay on rapid
diagnosis of extrapulmonary tuberculosis[J]. Int J Infect
Dis, 2019, 81:91-96.
[36] PEREZ-RISCO D, RODRIGUEZ-TEMPORAL D,
VALLEDOR-SANCHEZ I, et al. Evaluation of the
Xpert MTB/RIF Ultra assay for direct detection of Mycobacterium
tuberculosis complex in smear-negative
extrapulmonary samples[J]. J Clin Microbiol, 2018,
56(9): e00659-18.